Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Effect of desferrioxamine (DFO) and dihydroartemisinin (DHA) on P
2a1, a2)
You have a BMI between 30-34.99 and have at least one of these conditions: Diastolic heart failure (also called heart failure with preserved ejection fraction) Uncontrolled high blood pressure (also called hypertension) Chronic kidney disease at stage 3a or higher Prediabetes A previous heart attack (also called myocardial infarction) or stroke Blocked arteries in your legs or arms (also called peripheral artery disease) with symptoms You have a BMI between 27-29.99 and have at least one of these conditions: Prediabetes A previous heart attack (also called myocardial infarction) or stroke Blocked arteries in your legs or arms (also called peripheral artery disease) with symptoms Beneficiaries who receive GLP-1 medications through existing Medicare prescription drug coverage or are eligible through their existing Medicare Part D program arent eligible.
J Mol Endocrinol 8(3):213223
